HTB | HIV i-Base

HTB: no. 8 – plus HIV and COVID-19 (1 August 2021)

Featured HTB: no. 8 – plus HIV and COVID-19 (1 August 2021) 1 August 2021. Related: Editorial.
Featured HTB: no. 7 – plus HIV and COVID-19 (1 July 2021) 1 July 2021. Related: Editorial.
Featured HTB: no. 6 – plus HIV and COVID-19 (1 June 2021) 1 June 2021. Related: Editorial.
Featured HTB: no. 5 – plus HIV and COVID-19 (3 May 2021) 3 May 2021. Related: Editorial, Special reports.
Featured HTB: no. 4 – plus HIV and COVID-19 (1 April 2021) 1 April 2021. Related: Editorial.
Featured CROI 2021: First results using capsid inhibitor lenacapavir against MDR HIV: potential for six-monthly ART and PrEP 1 April 2021. Related: Conference reports, Antiretrovirals, CROI 2021 (virtual).
Featured In Memory: Timothy Ray Brown – the Berlin patient, the first person to be cured of HIV 14 October 2020. Related: In memory.
HIV positive people at increased risk of severe COVID-19 in large US cohort: clear links to CD4 and viral load 3 August 2021. Related: Early access, COVID-19: HIV and COVID-19 coinfection, COVID-19.
Neutralising antibody levels from COVID vaccines correlate negatively with age 2 August 2021. Related: Early access, COVID-19: vaccine research, COVID-19.
HPV vaccine prevent penile infections in young gay men 1 August 2021. Related: Early access, Coinfections and complications.
Outbreak of 469 symptomatic Delta cases in fully vaccinated adults during Bear Week 1 August 2021. Related: Early access, COVID-19: transmission & prevention, COVID-19.
i-Base appeal: please support i-Base with £5 or £10 a month 1 August 2021. Related: Editorial.
11th IAS Conference on HIV Science (IAS 2021) 1 August 2021. Related: Conference reports, IAS 11 virtual 2021.
IAS 2021: lenacapavir studies show impressive results in naive, extensive drug resistance and potential as PrEP 1 August 2021. Related: Conference reports, Antiretrovirals, IAS 11 virtual 2021.
IAS 2021: HIV pipeline drugs: CAB/RPV LA, fostemsavir, paediatric dolutegravir, lenacapavir, islatravir, MK-8507 and albuvirtide 1 August 2021. Related: Conference reports, Antiretrovirals, IAS 11 virtual 2021.
IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies 1 August 2021. Related: Conference reports, HIV prevention and transmission, Research studies.
IAS 2021: WHO report links HIV to 30% increased mortality from COVID-19: based on South African data 1 August 2021. Related: Conference reports, COVID-19: HIV and COVID-19 coinfection, COVID-19, IAS 11 virtual 2021.
IAS 2021: New demands for better transgender heath care: No data no more 1 August 2021. Related: Conference reports, HIV prevention and transmission, IAS 11 virtual 2021.
13th International Workshop on HIV Paediatrics 2021 1 August 2021. Related: Conference reports, Paediatric care, IAS 11 virtual 2021, Paediatric Workshop 13 virtual 2021.
Dolutegravir superior to standard-of-care in young children: results from the ODYSSEY trial 1 August 2021. Related: Conference reports, Paediatric care, Paediatric Workshop 13 virtual 2021.
UK Biobank study finds no link between CMV and cardiovascular disease: HIV not included 1 August 2021. Related: Coinfections and complications.
Phase 1 HIV mosaic vaccine study launched at Oxford university 1 August 2021. Related: HIV prevention and transmission, Vaccines and microbicides.
Ending the HIV epidemic (EHE) in the US 1 August 2021. Related: On the web.
Antibody responses to Pfizer vaccine in HIV positive people with high CD4 counts 1 August 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Third dose of mRNA vaccine improves antibody responses in kidney transplant recipients 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
US CDC recommends third vaccine dose in some groups 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Pfizer plans for third dose: questions over population need? 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Efficacy of Oxford/AZ and Pfizer vaccines against Delta variant in the UK 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Results from Novavax phase 3 study in the UK 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
WHO approves Chinese vaccines for emergency use 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Selected other vaccine studies 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
Efficacy of Chinese CoronaVac vaccine in Chile national programme 1 August 2021. Related: COVID-19: vaccine research, COVID-19.
NHS supports selected use of inhaled budesonide for COVID-19 in people at risk of severe events 1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
Reviews of ivermectin for COVID-19: evidence from RCTs is still needed 1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
RCT shows no impact of azithromycin in reducing symptoms of mild COVID-19 1 August 2021. Related: COVID-19: investigational drugs, COVID-19.
Variation in ACE2 levels are not related to outcomes from COVID-19 1 August 2021. Related: COVID-19: pathogenesis, COVID-19.
Future meetings and webinars 2021 1 August 2021. Related: Future meetings.
HTB: no. 8 – plus HIV and COVID-19 (1 August 2021) 1 August 2021. Related: PDFs.
5th Joint BHIVA/BASHH Conference 2021 1 July 2021. Related: Conference reports, Conference index, BHIVA/BASHH 5th Virtual 2021.
Few vertical HIV transmissions in the UK but contributing factors remain associated with inequality 1 July 2021. Related: Conference reports, Pregnancy.
Lenacapavir submitted to FDA as long-acting treatment for MDR HIV 1 July 2021. Related: Antiretrovirals.
US HIV treatment guidelines updated (June 2021) 1 July 2021. Related: Guidelines.
Predicting likelihood of post treatment control in HIV cure-related studies that interrupt ART 1 July 2021. Related: Cure research.
London HIV study of responses to COVID-19 vaccines and natural infection (SCAPE) 1 July 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19: research studies, COVID-19.
Failure of mRNA vaccines to produce antibody responses in late diagnosed HIV with low CD4 count and high viral load 1 July 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19: vaccine research, COVID-19.
Special report on background incidence of adverse events in vaccine studies 1 July 2021. Related: COVID-19: vaccine research, COVID-19.
Third vaccine dose increases immune response to 68% in French transplant recipients 1 July 2021. Related: COVID-19: vaccine research, COVID-19.
Third COVID-19 vaccine dose in US cohort of people on immune-suppressing treatment: safety and ethical issues 1 July 2021. Related: COVID-19: vaccine research, COVID-19: treatment access, COVID-19.
Plans for universal third vaccine dose for UK adults from September 1 July 2021. Related: COVID-19: vaccine research, COVID-19.
COVID-19 vaccines increase sperm quality: potential to help uptake 1 July 2021. Related: COVID-19: vaccine research, COVID-19.
Research approach to rapidly review candidate treatments for COVID-19: nine studies using ACTIV protocol 1 July 2021. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
US likely to have had SARS cases in December 2020 1 July 2021. Related: COVID-19: transmission & prevention.
COVID-19 treatment: tofacitinib, REGN bNAbs, convalescent plasma 1 July 2021. Related: COVID-19: investigational drugs, COVID-19.
Virology Education: monthly forums on COVID-19 1 July 2021. Related: COVID-19: on the web, COVID-19.
COVID-19 timeline: global events from the last 18 months 1 July 2021. Related: COVID-19: on the web, COVID-19.